Delivery Order SPE2DB22D2007-SPE2DB25FJ5KT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $19,104.45. This is a firm fixed-price, non-set-aside delivery order that will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $3,598.88. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,173.50 to AmerisourceBergen Drug Corp for the supply of Ivabradine HCl 5 mg tablets (60-count units) on September 16, 2025, with completion expected by September 17, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $8,002.50 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a 60-count quantity. The contract, awarded September 10, 2025, with completion targeted for September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.29 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Corlanor (ivabradine) 5 mg tablets in quantities of 60 units, with a ceiling value of $5,203.25 and an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,643.36 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 6, 2025, and scheduled for completion by September 8, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,266.36 by the Defense Logistics Agency (DLA) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract, which is not set-aside and competitively awarded, calls for the delivery of Ibsrela 50 mg tablets in quantities of 60 units. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $18,186.68 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg tablets (60 count) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 10, 2025, for IBSRELA 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $5,261.40 with a completion date of July 11, 2025, was competitively awarded with no set-aside designation. The award represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier to the...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5KTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for the supply of Ivabradine HCL 5 mg tablets in a 60-count quantity. The contract, executed on September 26, 2025, carries a ceiling value of $19,626.23 and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be completed by September 29, 2025, reflecting the expedited nature of this pharmaceutical procurement through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen Drug Corp's established capability to fulfill federal medical procurement requirements competitively and reflects its significant role as a critical pharmaceutical vendor within the federal healthcare supply ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 9/26/25 |